Assessment of small bowel function in critical illness: Potential role of citrulline metabolism

Journal of Intensive Care Medicine

Volumn 26, Issue 2, 2011, Pages 105-110

  Peters, J H C ^a   Beishuizen, A ^b   Keur, M B ^b   Dobrowolski, L ^b   Wierdsma, N J ^b   Van Bodegraven, A A ^b  

^a RED CROSS HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

biomarker; citrulline; critical illness; enterocyte function; glutamine

Indexed keywords

BIOLOGICAL MARKER; CITRULLINE; GLUTAMINE;

AMINO ACID METABOLISM; BACTERIAL TRANSLOCATION; CELL STIMULATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; ENTERIC FEEDING; EXPLORATORY RESEARCH; HUMAN; INTESTINE CELL; INTESTINE FUNCTION; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS;

BIOLOGICAL MARKERS; CITRULLINE; CRITICAL ILLNESS; ENTEROCYTES; HUMANS; INTESTINE, SMALL;

EID: 79953879406     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610387998     Document Type: Review

References (43)

1. Deitch EA. Nutrition and the gut mucosal barrier. Curr Opin Gen Surg. 1993:85-91.
2. Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil. 2005;26(5):383-391. (Pubitemid 41433676)
3. Strack van Schijndel RJ, Wierdsma NJ, van Heijningen EM, Weijs PJ, de Groot SD, Girbes AR. Fecal energy losses in enterally fed intensive care patients: an explorative study using bomb calorimetry. Clin Nutr. 2006;25(5):758-764. (Pubitemid 44426424)
4. Melichar B, Kohout P, Bratova M, Solichová D, Králí cková P, Zadák Z. Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol. 2001;127(5):314-318.
5. Oudemans-van Straaten HM, van der Voort PJ, Hoek FJ, Bosman RJ, van der Spoel JI, Zandstra DF. Pitfalls in gastrointestinal permeability measurement in ICU patients with multiple organ failure using differential sugar absorption. Intensive Care Med. 2002;28(2):130-138. (Pubitemid 34293824)
6. Heymsfield SB, Smith J, Kasriel S, et al. Energy malabsorption: measurement and nutritional consequences. Am J Clin Nutr. 1981;34(9):1954-1960. (Pubitemid 12235283)
7. Arnold J, Hendriks J, Ince C, Bruining H. Tonometry to assess the adequacy of splanchnic oxygenation in the critically ill patient. Intensive Care Med. 1994;20(6):452-456. (Pubitemid 24244933)
8. Kolkman JJ, Bargeman M, Huisman AB, Geelkerken RH. Diagnosis and management of splanchnic ischemia. World J Gastroenterol. 2008;14(48):7309-7320.
9. Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. Am J Physiol. 1981;241(6):E473-E480.
10. Wu G. Intestinal mucosal amino acid catabolism. J Nutr. 1998;128(8):1249-1252.
11. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology. 2003;124(5):1210-1219. (Pubitemid 36531797)
12. Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity. Am J Gastroenterol. 2007;102(12):2814-2819. (Pubitemid 350179333)
13. Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA. The citrulline generation test: proposal for a new enterocyte function test. Aliment Pharmacol Ther. 2008;27(12):1300-1310. (Pubitemid 351710701)
14. Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer. 2005;103(1):191-199. (Pubitemid 39665473)
15. Papadia C, Sherwood RA, Kalantzis C, et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol. 2007;102(7):1474-1482. (Pubitemid 46976295)
16. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. Transplant Proc. 2002;34(3):915-917.
17. Curis E, Nicolis I, Moinard C, Osowska S, et al. Almost all about citrulline in mammals. Amino Acids. 2005;29(3):177-205. (Pubitemid 41754486)
18. Wu G. Synthesis of citrulline and arginine from proline in enterocytes of postnatal pigs. Am J Physiol. 1997;272(6 pt 1):G1382-G1390.
19. van de Poll MC, Ligthart-Melis GC, Boelens PG, Deutz NE, van Leeuwen PA, Dejong CH. Intestinal and hepatic metabolism of glutamine and citrulline in humans. J Physiol. 2007;581(pt 2):819-827.
20. Wakabayashi Y, Jones ME. Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. J Biol Chem. 1983;258(6):3865-3872. (Pubitemid 13052878)
21. Wakabayashi Y, Yamada E, Hasegawa T, Yamada R. Enzymological evidence for the indispensability of small intestine in the synthesis of arginine from glutamate. I. Pyrroline-5-carboxylate synthase. Arch Biochem Biophys. 1991;291(1):1-8.
22. Kamoun P, Rabier D, Bardet J, Parvy P. Citrulline concentrations in human plasma after arginine load. Clin Chem. 1991;37(7):1287.
23. Collins JK, Wu G, Perkins-Veazie P, et al. Watermelon consumption increases plasma arginine concentrations in adults. Nutrition. 2007;23(3):261-266. (Pubitemid 46389568)
24. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000;119(6):1496-1505. (Pubitemid 32198675)
25. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27(3):328-339.
26. Ceballos I, Chauveau P, Guerin V, et al. Early alterations of plasma free amino acids in chronic renal failure. Clin Chim Acta. 1990;188(2):101-108. (Pubitemid 20150115)
27. Dechelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34(3):598-604.
28. Cynober LA. Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002;18(9):761-766. (Pubitemid 35286391)
29. Martens-Lobenhoffer J, Bode-Boger SM. Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;798(2):231-923.
30. Vente JP, von Meyenfeldt MF, van Eijk HM, et al. Plasma-amino acid profiles in sepsis and stress. Ann Surg. 1989;209(1):57-62. (Pubitemid 19044211)
31. Rhoads JM, Plunkett E, Galanko J, et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr. 2005;146(4):542-547. (Pubitemid 40469721)
32. Luo M, Fernandez-Estivariz C, Manatunga AK, et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome? JPEN J Parenter Enteral Nutr. 2007;31(1):1-7.
33. Jianfeng G, Weiming Z, Ning L, et al. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res. 2005;127(2):177-182. (Pubitemid 41080631)
34. Biolo G, Zorat F, Antonione R, Ciocchi B. Muscle glutamine depletion in the intensive care unit. Int J Biochem Cell Biol. 2005;37(10):2169-2179. (Pubitemid 41206829)
35. Peters JH, Dobrowolski LC, Wierdsma NJ, et al. The citrulline generation test in stable ICU patients: optimizing a new enterocyte function test. Gut. 2008;57(supp II):A350.
36. Jeevanandam M, Young DH, Ramias L, Schiller WR. Aminoaciduria of severe trauma. Am J Clin Nutr. 1989;49(5):814-822. (Pubitemid 19139782)
37. Jeevanandam M, Ramias L, Schiller WR. Altered plasma free amino acid levels in obese traumatized man. Metabolism. 1991;40(4):385-390.
38. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214(5):621-626.
39. Yu YM, Young VR, Castillo L, et al. Plasma arginine and leucine kinetics and urea production rates in burn patients. Metabolism. 1995;44(5):659-666.
40. Jensen GL, Miller RH, Talabiska DG, Fish J, Gianferante L. A double-blind, prospective, randomized study of glutamine-enriched compared with standard peptide-based feeding in critically ill patients. Am J Clin Nutr. 1996;64(4):615-621. (Pubitemid 26334242)
41. Long CL, Borghesi L, Stahl R, et al. Impact of enteral feeding of a glutamine-supplemented formula on the hypoaminoacidemic response in trauma patients. J Trauma. 1996;40(1):97-102. (Pubitemid 26045026)
42. Iresjo BM, Korner U, Larsson B, Henriksson BA, Lundholm K. Appearance of individual amino acid concentrations in arterial blood during steady-state infusions of different amino acid formulations to ICU patients in support of whole-body protein metabolism. JPEN J Parenter Enteral Nutr. 2006;30(4):277-285.
43. Sandstrom P, Trulsson L, Gasslander T, Sundqvist T, von Dobeln U, Svanvik J. Serum amino acid profile in patients with acute pancreatitis. Amino Acids. 2008;35(1):225-231. (Pubitemid 351799188)